VIRAT SIRISANTHANA, MD AND THIRA SIRISANTHANA, MD Disseminated infection with the fungus Penicillium marneffei is one of the most common opportunistic infection in human immunodeficiency virus (HIV) disease in northern Thailand. We report the clinical, laboratory and therapeutic features of 21 human immunodeficiency virus-infected children with disseminated P. marneffei who were prospectively followed. Significant clinical and laboratory features included generalized lymphadenopathy (90%), hep-
atomegaly (90%), body temperature >38. 5 o C (81%), papular skin lesions with central umbilication (67%), splenomegaly (67%), failure to thrive (52%), severe anemia (hemoglobin < 60 g/liter) (43%) and thrombocytopenia (platelet count <0.5 x 10 11 /liter) (21%). The response rate in patients who were treated with appropriate antifungal therapy (amphotericin B, fluconazole, or ketoconazole) was 82%. No relapse was observed in patients given ketoconazole prophylactically. Skin lesions, usually papules with central necrotic umbilication, provide the most significant clue to the diagnosis. Early diagnosis based on finding P. marneffei in the skin smear or lymph node provides the basis for prompt administration of antifungal therapy and improved outcome.
INTRODUCTION
Penicillium marneffei desease is endemic in Southeast Asian countries and China. 1, 2 . It can cause systemic mycosis in healthy and compromised hosts 1, 2 In the past, only a few cases of P. marneffei infection were reported even from endemic areas. Recently, the number of patients has increased dramatically [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and has occurred exclusively among patients infected with human immunodeficiency virus (HIV). 6, 11 The clinical and laboratory features of 86 adult patients with HIV infection who had disseminated P. marneffei infection had been reported from Chiang Mai. 16 Here we report 21 children with perinatally transmitted HIV infection who had disseminated P. marneffei infection.
METHODS
All HIV-infected children with disseminated P. marneffei infection who were seen at Chiang Mai University Hospital from April 1989 to January, 1995, were included in the study. In children older than 18 months the diagnosis of HIV infection was made when the child's serum was repeatedly reactive by both enzyme-linked immunosorbent assay (Enzymun-Test  Anti-HIV 1+2, Boehringer Mannheim GmbH Diagnostica) and particle agglutination test (Serodia  -HIV, Fujirebio Inc., Tokyo, Japan). In children younger than 18 months old, the diagnosis of HIV infection was made when the serum was repeatedly reactive and symptoms and signs of HIV infection or HIV-related conditions were present. The diagnosis of P. marneffei infection was made by isolation of the organism from clinical specimens, predominantly blood or specimen obtained from skin lesions. Methods of fungal isolation and mycologic characteristics of P. marneffei have been described previously. 11 In some patients, the diagnosis was made by microscopically demonstrating yeastlike organisms in the Wright's-stained skin smear. The smear was made by nicking the skin over the lesion with the lancet and scraping it; the fluid and tissue obtained were sent for culture as well as spread on a glass slide and stained. Yeastlike cells characteristic of P. marneffei were basophillic and appeared both inside and outside the macrophage. There were spherical, oval or elliptical and varied in diameter from 3 to 8 µm. Some yeastlike cells were seen with central septation (Fig. 1) . These findings are characteristic of P. marneffei. 16 Patients whose diagnosis was made before death were treated with amphotericin B (AMB), fluconazole (FLZ), or ketoconazole (KTZ). Selection of an antifungal agent for therapy was based on the decision of the attending physician and infectious disease consultant. AMB was given in a dosage of 0.5 to 1 mg/kg intravenously daily for about 6-8 weeks, until the total dose of 30-35 mg/kg was reached. FLZ in a dosage of 5 mg/kg daily was given for 6 weeks either intravenously or orally. KTZ was given in a dosage of 5 mg/kg orally daily for 6 weeks. After the initial course of treatment, all patients were given KTZ, 2.5 mg/kg orally daily as long-term prophylaxis.
Evaluation of clinical improvement was performed at regular intervals. Blood culture was taken intermittently every 1-2 weeks until sterile or until the end of treatment. Response to treatment was defined as resolution of fever, skin lesions, and other symptoms and signs of P. marneffei infection and abscence of fungal growth in the follow up blood cultures. Failure was definded as no clinical improvement or deterioration of symptoms and signs of P. marneffei infection and persistent of fungemia during the course of treatment.
RESULTS
Between April 1989, to January 1995, 23 children with disseminated P. marneffei infection were diagnosed at Chiang Mai University Hospital. Prospective data collection in all cases. One patient was an 8.5-year-old non-HIV-infected girl and a second was a 14-year-old thalassemic patient who acquired HIV through blood transfusion. The remaining 21 children had acquired HIV infection perinatally. In 16 of these 21 patients, P. marneffei infection was diagnosed by isolation of the fungus from the blood or from the blood and skin lesion ( Table 1) . P. marneffei was cultured from specimens obtained from the skin lesion only in 2 patients. In the remaining 3 patients the diagnosis was made microscopically by demonstrating yeastlike organisms characteristic of P. marneffei in the Wright'sstained skin smear (2 cases) or in the skin biopsy (1 case). During this same period 362 children with symptomatic HIV infection, diagnosed according to the Centers for Disease Control case definition 17 were seen at Chiang Mai University Hospital.
Clinical features. The clinical features of the 21 perinatally HIV-infected children with P. marneffei infection are shown in table 1. Some of the clinical data from the first 5 of these 21 patients have been reported. 19 Eighteen patients lived in Chiang Mai province and 3 came from other neighboring provinces. All 21 mothers acquired HIV infection heterosexually either by working as a prostitute or from husbands who had visited prostitutes. The median age at the time of presentation of disseminated P. marneffei infection was 32 months (range 4 months to 5.5 years). At the time of diagnosis of P.marneffei infection, all 21 patients had had clinical manifestations of HIV infection. Eleven patients could be classified as Category C, according to the new Centers for Disease Control classification of HIV infection in children 18 . These include wasting syndrome (5 patients), recurrent bacterial septicemia (3), cryptosporidiosis (2), brain atrophy (1), isosporiosis (1), Pneumocystis carinii pneumonia (1), disseminated cytomegalovirus infection (1), chronic diarrhea (1), and chronic fever (1). In 4 patients there had been 2 or more episodes of these conditions.
Fever was a major presenting symptom. Two of four patients who did not have raised body temperature were in a terminal condition at the time of presentation. Fourteen patients (67%) presented with papular skin lesions, the majority of which had central necrotic umbilication (Fig. 2) . They were predominantly found on the face and extremities.
Significant laboratory findings of these patients are shown in table 2. Chest roentgenography revealed abnormal findings in 10 patients. Three children had clinical and roentgenographic findings compatible with lymphoid interstitial pneumonitis. One patient had physical examination and roentgenographic findings diagnostic of ventricular septal defect. Lung necropsies were done in 2 patients who died with severe pneumonia. In one P. marneffei was the sole pathogen. In the other, P. marneffei, Pneumocystis carinii, and cytomegalovirus were seen in the lung tissue. Three patients presented with clinical and roentgenographic evidence of osteomyelitis. The bone lesions healed after treatment with antifungal drug(s).
Concurrent HIV-related opportunistic infections. Nine patients also had other HIV-related opportunistic infections at the same time the diagnosis of P. marneffei infection was made. These included nontyphoid Salmonella bacteremia (4 cases), cryptosporidiVol. 14 No. 11, Nov., 1995 THE PEDIATRIC INFECTIOUS DISEASE JOURNAL osis (2), Pseudomonas aeruginosa bacteremia (1), Pneumocystis carinii and cytomegalovirus pneumonia (1), and nontyphoid Salmonella bacteremia and herpes zoster (1) .
Response to antifungal therapy. Two patients whose diagnosis was made only by histopathologic demonstration of the organism presented with less severe symptoms and responded well to FLZ or KTZ given orally. In the remaining case where the fungus could not be isolated in culture, the patient responded to AMB. Of the 18 culture-proven cases, appropriate antifungal therapy was given in 11 ( Table 3) . Seven of 8 patients given AMB, 1 of 2 patients given FLZ and 1 patient given KTZ responded, giving an overall response rate of 82 %. One of the patients who responded to AMB developed renal tubular acidosis after having received a total dosage of 28 mg/kg; the treatment was changed to FLZ. There was no other adverse drug reaction in the other 10 patients given antifungal therapy. The patient who did not respond to AMB presented with severe illness and died after receiving only 5 mg/kg. The patient who did not respond to FLZ given intravenously had fungemia after 2 weeks of therapy. The treatment was changed to AMB, but the patient died after receiving a total dosage of 18 mg/kg. Of these 11 patients who were given appropriate anti- fungal therapy, 9 were diagnosed based on the finding of P. marneffei in the Wright's -stained skin smear (8 patients) or Wright's -stained lymph-node biopsy smear 1 and treated with antifungal drug several days before the culture results became available. All 7 culture-proven patients who did not received antifungal therapy died. Six of these patients did not have skin lesions and a correct diagnosis had not been made antemortem. One other paient whose diagnosis was made from the skin smear died during the first hour of admission.
Nine culture-proven cases and 3 cases diagnosed histopathologically responded to initial antifungal treatment. All were given KTZ prophylaxis. Two patients died of other causes and 2 were lost to follow-up within 1 month of initial antifungal treatment. In the remaining 8 patients whose mean follow-up was 6.8 months, no relapse of P. marneffei infection was found.
DISCUSSION
P. marneffei, the only Penicillium species that is dimorphic, was first reported by Capponi et al. 19 as a disease agent of the bamboo rat (Rhizomys sinensis) in 1956. The first report of natural human infection with P. marneffei was in 1973 in a 61-year-old missionary with Hodgkin's disease who had had a splenectomy; he had been living in Southeast Asia. 21 Since then 125 patients with P. marneffei infection have been reported in the English literature. Almost all were residents of Thailand, the Guangxi province of China, or Hong Kong or were visitors to these areas. Supparatpinyo et al. 16 reported 86 adult patients with HIV and disseminated P. marneffei infection from Chiang Mai. Similar to that report our 21 pediatric patients with HIV and diseminated P. marneffei infection were diagnosed during a relatively short period from April 1989 to January 1995. No case had been diagnosed in Thailand before 1989. This recent increase in the number of patients coincides with the explosive HIV/acquired immunodeficiency syndrome (AIDS) epidemic in northern Thailand. 22 There are only 6 reported cases of P. marneffei infection in children outside the Chiang Mai area. 1, 2, [23] [24] [25] Only 1 of these 6 cases, an 11-year-old hemophiliac from Hong Kong, was also infected by HIV.
It has been suggested that P. marneffei infection be regarded as another AIDS-defining illness. 6, 9, 11, 16 Our finding that 19 (90%) of our patients were classified as Center for Disease Control Category B or C and that 9 patients had concurrent HIV-related opportunistic infections supported this suggestion. In our study the median age at the time of diagnosis of P. marneffei infection was 32 months. In a similar group of vertical HIV-infected children seen during the same period, the median age at the time of diagnosis of other opportunistic infection was 7 months. 26 Thus P. marneffei infection occurred late in the course of HIV infection. This is consistent with the finding by Supparatpinyo et al. 16 that the average CD4 count in HIV-infected adult patients with disseminated P. marneffei infection was 9/µL.
Many of the clinical features in our patients were not specific for P. marneffei infection and could be caused by HIV or other HIV-related opportunistic infection. A characteristic clinical finding was the skin lesion, seen in two-thirds of our patients, most commonly occurred on the face and extremities. The lesions were usually papules with central necrotic umbilication. The septate yeastlike organisms seen in the skin smear from these lesions is diagnostic of P. marneffei.
11 Fifty-seven percent of our patients had low hemoglobin values and one-third had thrombocytopenia, both of which were uncommon in our other symptomatic HIV-infected children and might also be clues to the diagnosis of systemic P. marneffei infection. P. marneffei has been isolated from the bone marrow of all 26 adult patients in whom aspiration were performed. 16 The case fatality rate of patients with P. marneffei infection is very high. 1, 2, 12, 23 This is mostly because of failure to make a timely diagnosis. There was often a delay in starting antifungal therapy. In our study, 6 patients who presented with nonspecific symptoms and signs without skin lesions died without antifungal treatment. The immediate mortality rate in those given appropriate antifungal therapy was 18 %. In 9 of these 11 patients, the diagnosis was based on finding P. marneffei in the skin smear or lymph node biopsy smear, and antifungal drug was given before the culture result was available. Thus it is clear that early diagnosis and treatment improve survival. In the report of treatment and outcome of adult patients with HIV and P. marneffei infection, many who responded to initial therapy relapsed within 6 months. 27 In our study all patients who responded to initial therapy were given KTZ as long term prophylaxis. There was no relapse in any of the patients after a mean follow-up period of 6.8 months.
Studies of animal and human infection with P. marneffei indicated that the fungus is endermic in Thailand. 1, 6, 10, 11 China, 2, 23 Hong Kong, 5, 8, 9, 12 Vietnam 25, [28] [29] [30] and Indonesia. 31 Thailand has one of the most explosive HIV/AIDS epidemic in the world. It is estimated that 6000-7200 HIV-infected children are born in Thailand every year. 22 Many of these children will develop systemic P. marneffei infection. As the HIV/AIDS pandemic spreads across Southeast Asia and China, infection with P. marneffei will become an important public health issue. Medical practitioners in these areas should be aware of the clinical and laboratory features of this disseminated fungal infection.
